Trelagliptin Succinate: A Weekly Solution for Type 2 Diabetes

Experience improved glycemic control with our innovative once-weekly DPP-4 inhibitor.

Get a Quote & Sample

Product Advantages

Enhanced Patient Compliance

The once-weekly dosing of Trelagliptin Succinate is a major advantage for Type 2 Diabetes management, significantly improving medication adherence compared to daily regimens.

Effective Glycemic Control

By effectively targeting DPP-4, Trelagliptin Succinate helps lower HbA1c levels and reduce daily blood glucose fluctuations, contributing to better overall glycemic control.

Improved Metabolic Profile

Beyond its primary function, Trelagliptin Succinate also demonstrates benefits in reducing cholesterol and low-density lipoprotein (LDL) levels, supporting a healthier metabolic profile.

Key Applications

Type 2 Diabetes Mellitus Treatment

This is the primary indication for Trelagliptin Succinate, where its DPP-4 inhibitory action aids in managing blood glucose levels.

Glycemic Variability Reduction

By prolonging incretin activity, Trelagliptin Succinate helps to smooth out daily blood glucose fluctuations, a crucial aspect of diabetes care.

Adjunct Therapy

It can be used as an add-on treatment when other therapies like metformin are not sufficient to reach glycemic goals.

Cholesterol Management Support

The positive impact on cholesterol and LDL levels makes it a supportive agent for patients managing multiple cardiovascular risk factors associated with T2DM.